Get Your Medical Marijuana Card Today - Fast & Easy!

DISCLAIMER: This article is for educational purposes only and should not be considered medical advice. Consult your doctor before making any decisions about medical marijuana treatment. The information provided here does not substitute for professional medical consultation, diagnosis, or treatment.
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, disrupting communication between the brain and the rest of the body.
The body’s immune system mistakenly attacks myelin, the protective fatty sheath that surrounds nerve fibers in the brain and spinal cord. When myelin is damaged, nerve signals slow down or become blocked entirely. This results in symptoms that can impact daily life.
Texas is home to an estimated 20,000 people living with MS. Multiple sclerosis (MS) typically develops in individuals between the ages of 20 and 40, although it can occur at any age.
Women are diagnosed with MS about three times more often than men. While the exact cause remains unknown, researchers believe it results from a combination of genetic predisposition and environmental factors.

MS earned its name—”multiple sclerosis” meaning “many scars”—because of the widespread lesions or scar tissue that develop throughout the brain and spinal cord.
These lesions can appear anywhere in the central nervous system. MS symptoms depend on the patient. Some patients experience mild symptoms with little impact on their daily activities, while others face issues with mobility and cognition.
The unpredictable nature of MS can lead to sudden onset and daily fluctuations in the severity of symptoms. This not only affects patients but also their loved ones, employers, and doctors who must adapt to the changing nature of the condition.
Texas recognized multiple sclerosis as a qualifying condition for medical marijuana in 2019. Patients can access low-THC cannabis products that can help manage spasticity, pain, sleep disorders, and other debilitating symptoms.

The most common form, affecting approximately 85% of patients.
RRMS is characterized by defined periods of symptom flare-ups (relapses) followed by partial or complete recovery periods (remissions).
During remissions, symptoms may improve or disappear entirely. Relapses can last days, weeks, or months.
People who initially had RRMS can develop Secondary Progressive MS (SPMS). In this phase, the disease progresses more steadily, with or without occasional relapses.
Most people with RRMS will eventually transition to SPMS, usually 10–20 years after their initial diagnosis.

PPMS affects about 10–15 percent of people. It’s characterized by gradually worsening symptoms from the onset, without distinct relapses and remissions.
PPMS patients experience a steady decline in function (rate of progression can vary). PPMS is diagnosed later in life (around age 40-50), affecting men and women.
PRMS is the rarest form, affecting less than 5% of people with MS. This type shows steady disease progression from the beginning but also includes clear acute relapses.
Unlike SPMS, people with PRMS experience continuous disease progression between relapses, with little to no recovery periods.
CIS is caused by inflammation or demyelination in the central nervous system. While CIS isn’t technically MS, people who experience it may go on to develop the disease.
Each type of MS responds differently to various treatments, including medical marijuana. The type and severity of symptoms, the frequency of relapses, and the rate of progression all influence cannabis-based treatments.

CBD works through several pathways that don’t involve traditional cannabinoid receptors. It modulates calcium channels, affects neurotransmitter release, and influences immune cell behavior.
THC (in low concentrations) can complement CBD’s effects by providing additional anti-inflammatory and muscle-relaxing benefits.
Different cannabinoid ratios may work better for specific symptoms. Higher CBD ratios work best with daytime use. The Texas program’s low-THC formulations can maximize therapeutic benefits while minimizing that “high” feeling.
Here are more ways medical marijuana can help MS patients:
Clinical studies show that people with MS who used nabiximols (THC-CBD sprays) were 2.5 times more likely to report a decrease in spasticity severity compared to those taking a placebo.
Research indicates that approximately every second patient can benefit from achieving a relevant reduction in spasticity when using THC-CBD combinations.
CBD’s anti-inflammatory and analgesic properties work through multiple pathways to reduce pain signals.
Studies have found that when people with secondary progressive MS used oral cannabinoid sprays containing both CBD and THC, they experienced a reduction in both perceived pain and its physical markers.

Sleep disturbances are common in MS, often caused by pain, spasticity, or bladder dysfunction.
CBD has demonstrated effectiveness in improving sleep quality and reducing sleep-related disruptions. The muscle-relaxing effects of cannabinoids can also reduce nighttime muscle spasms that interrupt sleep.
Research published in Frontiers in Immunology shows that CBD and THC together can help suppress neuroinflammation. This may not only reduce current symptoms but also potentially slow disease progression.
Cannabis-based treatments may help improve bladder symptoms by reducing muscle spasms in the bladder.
While results vary, some patients report that certain CBD formulations help manage the overwhelming fatigue that affects about 80% of MS patients.
The chronic, unpredictable nature of MS can lead to depression and anxiety in up to 50% of patients. CBD’s anxiolytic properties may help manage these mental health challenges.

Yes, multiple sclerosis patients in Texas can qualify for medical marijuana through the state’s Compassionate Use Program.
The Texas Compassionate Use Program covers the treatment of MS, among other qualifying conditions.
Starting September 1, 2025, the program allows lotions, transdermal patches, suppositories, and approved inhalation devices, including nebulizers, vaporizers, and inhalers, when approved by a prescribing doctor.

Connect with one of their licensed doctors who are registered with the state’s Compassionate Use Program. TeleLeaf offers same-day appointments and certification. making the process more accessible for MS patients who may have mobility challenges.
Sign up for a Texas medical marijuana card.
During your consultation, one of our licensed doctors will review your medical history and MS diagnosis. If you qualify, they will enter your prescription directly into the Compassionate Use Registry of Texas (CURT) system.
Once your prescription is in the system, you can visit any licensed dispensaries in Texas. Starting September 1, 2025, the state will have up to 15 total dispensing organizations (up from the current 3), improving access statewide.
You’ll need to provide your ID, name, date of birth, and the last five digits of your Social Security Number to purchase your medication.
New in 2025: Prescriptions are now valid for one year with four 90-day refills, which can be partially filled within each 90-day period, providing greater flexibility for patients.
You can buy your cannabis from one of the dispensaries below:

Living with multiple sclerosis creates many challenges that extend far beyond the physical symptoms:

Living with multiple sclerosis doesn’t have to mean accepting a life limited by uncontrolled symptoms. Medical marijuana through Texas’s Compassionate Use Program represents a proven treatment option that has helped thousands of MS patients regain control over their symptoms and reclaim their quality of life.
Don’t let another day pass wondering if better symptom control is possible. TeleLeaf’s makes it easy to get evaluated from the comfort of your home.
Contact us and take the first step toward the relief you deserve.

Medical marijuana has been legal in Texas in limited forms for several years, but access has historically been restricted. In 2015, the state introduced the Texas Compassionate Use Program (CUP), and over time, lawmakers expanded the list of qualifying conditions through updates in 2019 and 2021. Today, many Texans with chronic or debilitating medical conditions can legally obtain low-THC cannabis as part of their treatment.
Although standard treatments like corticosteroids and disease-modifying drugs are typically used to manage multiple sclerosis (MS), they don’t always effectively relieve symptoms such as pain, muscle stiffness, or fatigue. As a result, some individuals consider medical marijuana as an alternative approach to help manage these symptoms and enhance their quality of life, particularly when conventional options prove insufficient.